Skip to content

Exploring metastatic colorectal cancer‘s characteristic Intestina microbiota markers and risk prediction model based on multiomics

Exploring metastatic colorectal cancer‘s characteristic Intestina microbiota markers and risk prediction model based on multiomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092270
Enrollment
Unknown
Registered
2024-11-13
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

healthy volunteers group :none
metastatic CRC group:none
non-metastatic CRC group:none

Sponsors

Zhejiang Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Colorectal cancer patients: 1) Age range: 18-75 years old, gender not limited; 2) Patients with colorectal cancer and >= 1 metastasis, clinically classified as stage III, who meet the diagnostic criteria and are confirmed by pathology; 3) The subjects voluntarily joined this study, signed an informed consent form, and showed good compliance. Healthy volunteers: 1) Age range: 18-75 years old, gender not limited; 2) No inflammatory gastrointestinal disease, no history of gastrointestinal surgery in the past 5 years, and no obvious gastrointestinal discomfort symptoms in the past 2 weeks; 3) The subjects voluntarily joined this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Pregnant, breastfeeding, or unable to cooperate; 2) History of other primary tumors; 3) Suffering from dementia or significant mental state changes that prevent them from understanding or expressing informed consent; 4) Fecal discharge through a stoma; 5) Individuals who have a history of taking antibiotics or probiotics within the first 4 weeks of collecting fecal samples; 6) Diarrhea, vomiting, nausea, and other gastrointestinal discomfort within 2 weeks prior to enrollment; 7) Serious damage to the heart, liver, kidneys, or hematopoietic system; 8) The condition is severe, with obvious cachexia, and the expected survival time is <= 3 months; 9) The researchers believe that the subjects are unable to complete the study or comply with the requirements of the study.

Design outcomes

Primary

MeasureTime frame
Differences in gut microbiota;

Countries

China

Contacts

Public ContactSun Leitao

Zhejiang Provincial Hospital of Chinese Medicine

sunnylt@zcmu.edu.cn+86 135 8813 5011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026